Medical News

Latest Medical News

On 22 December 2025, the US Food and Drug Administration (FDA) approved the Wegovy® pill (oral semaglutide 25 mg tablet) as the first oral GLP-1 receptor agonist for chronic weight management. Indica...

Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image